JEPrifa- M

Name: JEPrifa- M
Brand: AIDLEY FORMULATIONS
Price: 2400.0 INR
Availability: InStock

Price 2400.0 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

JEPrifa- M Specification

Composition
Metformin Hydrochloride Prolonged Release and Repaglinide Tablets

Product Name
JEPrifa- M

Prescription/Non Prescription
Prescription

Type
Oral Anti-diabetic Tablet

Indication
Management of Type 2 Diabetes Mellitus

Strength
Metformin HCl PR 500 mg + Repaglinide 0.5 mg

Storage Condition
Store in a cool, dry, and dark place

JEPrifa- M Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
1 Box Per Week

Delivery Time
1 Week

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
PACKING- 10X10 Alu-Alu

Main Domestic Market
All India

Certifications
GMO , GMP , AND ISO CERTIFIED

About JEPrifa- M

Rifaximin and Metronidazole which treat infectious diarrhoea. These antibiotics work in the digestive tract by killing the bacteria and other microorganisms that cause diarrhoea. This treats your infection and relieves symptoms.

Dual Action Glycemic Control

JEPrifa- M leverages the combined benefits of Metformin and Repaglinide to provide robust management of Type 2 Diabetes Mellitus. The synergistic action helps to regulate blood glucose throughout the day by targeting both insulin resistance and insulin secretion.

Convenient Oral Therapy

Designed as a once-daily oral tablet, JEPrifa- M simplifies diabetes management by reducing the frequency of dosing compared to multiple separate medications. Its prolonged release formulation ensures steady medication levels, optimizing glucose control.

Quality Manufacturing in India

Produced by accredited manufacturers and suppliers in India, JEPrifa- M adheres to stringent quality standards. This ensures efficacy and safety for patients who rely on consistent diabetic care.

FAQ's of JEPrifa- M:

Q: How does JEPrifa- M help manage Type 2 Diabetes Mellitus?

A: JEPrifa- M contains Metformin Hydrochloride Prolonged Release and Repaglinide, which work together to control blood sugar. Metformin decreases glucose production in the liver and improves insulin sensitivity, while Repaglinide stimulates rapid insulin secretion to control mealtime sugar spikes.

Q: What is the proper way to take JEPrifa- M tablets?

A: JEPrifa- M should be taken exactly as prescribed by your doctor, generally with meals to reduce gastrointestinal side effects and to enhance its blood sugar-lowering effect. Do not crush or split the tablet, and swallow it with water.

Q: When should JEPrifa- M be used during the course of diabetes treatment?

A: JEPrifa- M is utilized in adults diagnosed with Type 2 Diabetes Mellitus, especially when diet, exercise, and single-agent therapy are inadequate to control blood glucose. Always consult your healthcare provider about the timing and suitability for your condition.

Q: Where should JEPrifa- M tablets be stored?

A: These tablets should be kept in a cool, dry, and dark place to maintain their stability and effectiveness. Avoid exposure to heat, moisture, or direct sunlight.

Q: What are the benefits of using JEPrifa- M compared to other anti-diabetic medications?

A: JEPrifa- M offers the advantage of dual-action glycemic control, targeting both fasting and post-meal blood sugar levels. Its prolonged release formulation and combined therapy can simplify dosing and improve overall blood glucose management.

Q: Is a prescription required to obtain JEPrifa- M?

A: Yes, JEPrifa- M is a prescription-only medication. It should only be used under the supervision and guidance of a qualified healthcare professional.

Tell us about your requirement